[1]Saarikettu J, Ovod V, Vuoksio M, et al. Monoclonal antibodies against human Tudor-SN[J]. Hybridoma (Larchmt), 2010,29(3):231
[2]Rodríguez L, Ochoa B, Martínez M J. NF-Y and Sp1 are involved in transcriptional regulation of rat SND p102 gene[J]. Biochem Biophys Res Commun, 2007,356(1):226
[3]Broadhurst M K, Lee R S, Hawkins S, et al. The p100 EBNA-2 coactivator: a highly conserved protein found in a range of exocrine and endocrine cells and tissues in cattle[J]. Biochim Biophys Acta, 2005,1681(2/3):126
[4]Zhao C T, Shi K H, Su Y, et al. Two variants of zebrafish p100 are expressed during embryogenesis and regulated by Nodal signaling[J]. FEBS Lett, 2003,543(1/3):190
[5]Liu X, Dong L, Zhang X, et al. Identification of p100 target promoters by chromatin immunoprecipitation-guided ligation and selection (ChIP-GLAS)[J]. Cell Mol Immunol, 2011,8(1):88
[6]Gao X, Zhao X, Zhu Y, et al. Tudor staphylococcal nuclease (Tudor-SN) participates in small ribonucleoprotein (snRNP) assembly via interacting with symmetrically dimethylated Sm proteins[J]. J Biol Chem, 2012,287(22):18130
[7]Su C, Zhang C, Tecle A, et al. Tudor staphylococcal nuclease (Tudor-SN), a novel regulator facilitating G1/S phase transition, acting as a co-activator of E2F-1 in cell cycle regulation[J]. J Biol Chem, 2015,290(11):7208
[8]Gao X, Fu X, Song J, et al. Poly(a)(+) mRNA-binding protein Tudor-SN regulates stress granules aggregation dynamics[J]. FEBS J, 2015,282(5):874
[9]Saarikettu J, Ovod V, Vuoksio M, et al. Monoclonal antibodies against human Tudor-SN[J]. Hybridoma (Larchmt), 2010,29(3):231
[10]Ran F A, Hsu P D, Wright J, et al. Genome engineering using the CRISPR-Cas9 system[J]. Nat Protoc, 2013,8(11):2281
[11]Yu L, Liu X, Cui K, et al. SND1 Acts downstream of TGFβ1 and upstream of smurf1 to promote breast Cancer metastasis[J]. Cancer Res, 2015,75(7):1275
[12]Gilbert L A, Larson M H, Morsut L, et al. CRISPR-Mediated modular RNA-Guided regulation of transcription in eukaryotes[J]. Cell, 2013,154(2):442
[13]Ran F A, Hsu P D, Lin C Y, et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity[J]. Cell, 2013,154(6):1380
[1]杨娅楠,王 媛,左志宇,等.人GRP94基因慢病毒载体构建及稳定表达GRP94蛋白的人宫颈癌HeLa细胞株筛选及鉴定[J].天津医科大学学报,2017,23(04):290.
YANG Ya-nan,WANG Yuan,ZUO Zhi-yu,et al.Construction of human GRP94 lentivirus vector and its application in screening human cervical cancer cell line HeLa for stable expression[J].Journal of Tianjin Medical University,2017,23(06):290.
[2]董 旭,张兆域,苟芳琳,等.利用CRISPR/Cas9 系统构建稳定敲除CBX2基因的A549细胞系[J].天津医科大学学报,2018,24(05):395.
DONG Xu,ZHANG Zhao-yu,GOU Fang-lin,et al.Construction of CBX2 gene knockout stable A549 cell line with CRISPR /Cas9 system[J].Journal of Tianjin Medical University,2018,24(06):395.
[3]扈利红,邱宝晨,辛灵彪,等.长链非编码RNA(AC073934.6)慢病毒质粒构建及其对HEY和HeLa细胞系SND1表达的影响[J].天津医科大学学报,2020,26(06):505.
HU Li-hong,QIU Bao-chen,XIN Ling-biao,et al.Construction of lncRNA(AC073934.6) lentiviral plasmid and its effects on SND1 expression in HEY and HeLa cell lines[J].Journal of Tianjin Medical University,2020,26(06):505.
[4]卢鑫,任媛媛,葛林,等.NNMT基因启动子双荧光素酶报告系统的构建及其与SND1靶向关系的验证[J].天津医科大学学报,2021,27(04):413.
LU Xin,REN Yuan-yuan,GE Lin,et al.Construction of NNMT promoter dual luciferase reporter system and verification of its targeting relationship with SND1[J].Journal of Tianjin Medical University,2021,27(06):413.
[5]杨欢,冯玉梅.FOXQ1敲除乳腺癌MCF7细胞株的构建及其功能初探[J].天津医科大学学报,2023,29(05):500.
YANG Huan,FENG Yu-mei.Construction of FOXQ1 knockout MCF7 breast cancer cell line and itspreliminary functional exploration[J].Journal of Tianjin Medical University,2023,29(06):500.
?作者简介 刘郁莹(1986- ),女,硕士在读,研究方向:肿瘤免疫;
通信作者:杨洁,Email:yangji@tmu.edu.cn。
?